Data Source: Finviz
Tag: Biotech
Be in the know. 10 key reads for Tuesday…
- Biotech Giant Surges On Plan To Test Coronavirus Drug In Humans (Investor’s Business Daily)
- Flu and HIV Drugs Show Efficacy Against Coronavirus (The Scientist)
- The Final Frontier of Streaming: ViacomCBS Launches Star Trek (Barron’s)
- OPEC Scrambles to React to Falling Oil Demand From China (New York Times)
- Oil rebounds on potential for further OPEC+ supply cuts (Street Insider)
- How an Och-Less Och-Ziff Changed Its Attitude, Its Leadership – and Its Name (Institutional Investor)
- Global junk bond issuance hits monthly record (Financial Times)
- Here are the risks to watch in the CLO market, says industry group made famous by ‘The Big Short’ (MarketWatch)
- YouTube brought in $15 billion in advertising revenue in 2019 — 9 times more than Google paid to acquire the site 14 years ago. (Business Insider)
- A Hedge Fund With 29% Return Record Is Shorting Tesla Bonds (Bloomberg)
Be in the know. 10 key reads for Monday…
- Saudis Weigh Large 1M barrel/day Oil Cuts in Response to Coronavirus (Wall Street Journal)
- OPEC+ considering further 500,000 bpd oil output cut: Sources (CNBC)
- Gilead Drug to Undergo Human Trials in China to Cure Coronavirus (Bloomberg)
- Gilead Sciences (GILD) Shares Surges as Remdesivir May Be Effective in Treating Coronavirus (Street Insider)
- Experimental drug for coronavirus to be tested in Wuhan (Global Times)
- Cocktail of flu, HIV drugs appears to help fight coronavirus: Thai doctors (Reuters)
- Toronto patient with 1st confirmed case of coronavirus discharged from hospital (CityNews)
- The ‘Odd’ Part of the Economy That Baffles Steve Schwarzman (Institutional Investor)
- He Really, Really Wants to Win at Cornhole (Wall Street Journal)
- The Rotation To Value Is Inevitable (ZeroHedge)
Be in the know. 10 key reads for Saturday…
- 4 Bargains to Be Found Among Stocks Hit by Coronavirus Fears (Barron’s)
- James Bond’s favorite car maker Aston Martin gets rescue investor (New York Post)
- UK formally leaves the European Union and begins Brexit transition period (CNBC)
- What Third Point Is Worried About in 2020 (Institutional Investor)
- S&P 500 wipes out gain for the year on coronavirus fears (Financial Times)
- The Inner Game: Why Trying Too Hard Can Be Counterproductive (Farnam Street)
- How Warren Buffett Made 50% Returns During His Partnership Days | Warren Buffett’s Investment Strategy Explained (Macro-Ops)
- Eight Things I Never Knew About Jack Dorsey (Ramp Capital)
- Ray Dalio Is Still Driving His $160 Billion Hedge-Fund Machine (WSJ)
- Drugmakers Are Racing to Develop a Coronavirus Vaccine (Barron’s)
Podcast – Hedge Fund Tips with Tom Hayes – Episode 5
Article referenced in podcast above:
The “‘Great Wall’ of Worry” Stock Market (and Sentiment Results)…
Biotech (top weights) Earnings Estimates/Revisions
In the spreadsheet above I have tracked the earnings estimates for the Nasdaq Biotech ETF (IBB) top 30 weighted stocks. Continue reading “Biotech (top weights) Earnings Estimates/Revisions”
Be in the know. 10 key reads for Friday…
- Fed moves to ease some restrictions under the Volcker rule (CNBC)
- Russia’s Ministry of Health names three drugs that can treat new Chinese coronavirus (RT)
- OPEC curbs, supply risks to buoy oil prices in 2020: Reuters poll (Reuters)
- New coronavirus: How soon will a treatment be ready and will it work? (New Scientist)
- After Brexit, the EU Will Have to Be Flexible, Too (Barron’s)
- Brexit is happening tonight: Here’s how we got here, and what comes next (CNBC)
- Biotech Giant Biogen Banks On Alzheimer’s Approval In 2020 Outlook (Yahoo! Finance)
- Ray Dalio: We ‘Don’t Have a Clue’ How Coronavirus Will Impact Markets (Institutional Investor)
- Trump set for acquittal as bid to call witnesses falters (Financial Times)
- Pound Ends Tough Month on a Bright Note After BOE Decision (Bloomberg)
Be in the know. 10 key reads for Thursday…
- BoE’s Carney says rate cut would have led to above-target inflation (Reuters)
- Biogen Rallies After Q4 Earnings Top Views (Investor’s Business Daily)
- Ken French: ‘There Is No Way to Tell’ If Value Premium Is Disappearing (Institutional Investor)
- Alibaba Stock Looks Like a Buy on China Virus Fears (Barron’s)
- The one word that defined Davos, investing in India’s hyper-growth, and fading recession fears (Business Insider)
- Here’s what is worrying one stock-market bull (MarketWatch)
- OPEC May Move Up Meeting As Coronavirus Continues To Batter Oil Prices (OilPrice)
- US Oil Exports Could Explode After Once In A Lifetime Power Shift In China (OilPrice)
- US energy ‘junk’ bonds hammered by oil plunge (Financial Times)
- The “‘Great Wall’ of Worry” Stock Market (and Sentiment Results)…(ZeroHedge)
Be in the know. 8 key reads for Tuesday…
- 5 reasons coronavirus fears are overblown — and 14 stocks to buy now – (MarketWatch)
- U.S. Drugmakers Ship Therapies to China, Seeking to Treat Coronavirus (Wall Street Journal)
- Yahoo! Finance TV Appearance on Monday (Video) (Hedge Fund Tips)
- The S&P 500 Just Broke a Streak of Not Moving 1%. Here’s What History Says Happens Next. (Barron’s)
- The Coronavirus Slammed Stocks. How the Fed and Beijing Can Help the Economy. (Barron’s)
- Investors Poured Billions Into This Strategy. It’s Not Panning Out. (Institutional Investor)
- Lockheed Martin beats estimates, raises sales forecast on higher F-35 deliveries (Reuters)
- Ultrafast Trading Costs Stock Investors Nearly $5 Billion a Year, Study Says (Wall Street Journal)


